People · Operator
Named in public records as an officer, director or promoter · active 2021–2026 · Medical Devices, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NexEos Diagnostics, Inc. | — | Medical Devices | Series A | $25.7M | $7.9M | 2023 |
| ViTToria Biotherapeutics, Inc. | — | Biotechnology | Series A | $8.7M | $188.2M | 2021 |
Nicholas Siciliano at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nicholas Siciliano on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dennis Langer | 1 | 9 |
| Stephen Tullman | 1 | 7 |
| Geeta Vemuri | 1 | 7 |
| Bruce Peacock | 1 | 5 |
| Jeff Himawan | 1 | 4 |
| Leon Moulder | 1 | 3 |
| Christopher Molineaux | 1 | 2 |
| Preston Noon | 1 | 1 |
| Theresa Mansi | 1 | 1 |
| Louis Manzi | 1 | 1 |
| Nicholas Sicilano | 1 | 1 |
| Jeffrey Himawan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.